Jump to main content

博士論文

CRISPR loss-of-function screen identifies the Hippo signaling pathway as the mediator of regorafenib efficacy in hepatocellular carcinoma

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Digital data available

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

DOI[10.3390/cancers11091362]to the data of the same series

CRISPR loss-of-function screen identifies the Hippo signaling pathway as the mediator of regorafenib efficacy in hepatocellular carcinoma

Persistent ID (NDL)
info:ndljp/pid/12317113
Material type
博士論文
Author
末村, 茂樹
Publisher
末村, 茂樹
Publication date
2020
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
大阪大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
CRISPR loss-of-function screen identifies the Hippo signaling pathway as the mediator of regorafenib efficacy in hepatocellular carcinoma
Author/Editor
末村, 茂樹
Publication, Distribution, etc.
末村, 茂樹
Publication Date
2020
Publication Date (W3CDTF)
2020
Alternative Title
CRISPRライブラリーを用いた機能欠損型遺伝子スクリーニングによる、肝細胞癌に対するレゴラフェニブ治療効果修飾因子としてのHippo経路の同定
Degree grantor/type
大阪大学
Date Granted
2020-02-29
Date Granted (W3CDTF)
2020-02-29